216 related articles for article (PubMed ID: 30865517)
21. Structures of the human LONP1 protease reveal regulatory steps involved in protease activation.
Shin M; Watson ER; Song AS; Mindrebo JT; Novick SJ; Griffin PR; Wiseman RL; Lander GC
Nat Commun; 2021 May; 12(1):3239. PubMed ID: 34050165
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation.
Yu Y; Zhang L; Li X; Run X; Liang Z; Li Y; Liu Y; Lee MH; Grundke-Iqbal I; Iqbal K; Vocadlo DJ; Liu F; Gong CX
PLoS One; 2012; 7(4):e35277. PubMed ID: 22536363
[TBL] [Abstract][Full Text] [Related]
23. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose.
Hu Y; Suarez J; Fricovsky E; Wang H; Scott BT; Trauger SA; Han W; Hu Y; Oyeleye MO; Dillmann WH
J Biol Chem; 2009 Jan; 284(1):547-555. PubMed ID: 19004814
[TBL] [Abstract][Full Text] [Related]
24. O-GlcNAcase deficiency suppresses skeletal myogenesis and insulin sensitivity in mice through the modulation of mitochondrial homeostasis.
Wang X; Feng Z; Wang X; Yang L; Han S; Cao K; Xu J; Zhao L; Zhang Y; Liu J
Diabetologia; 2016 Jun; 59(6):1287-96. PubMed ID: 26993634
[TBL] [Abstract][Full Text] [Related]
25. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
[TBL] [Abstract][Full Text] [Related]
26. Functional significance of O-GlcNAc modification in regulating neuronal properties.
Hwang H; Rhim H
Pharmacol Res; 2018 Mar; 129():295-307. PubMed ID: 29223644
[TBL] [Abstract][Full Text] [Related]
27. Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.
Akan I; Olivier-Van Stichelen S; Bond MR; Hanover JA
J Neurochem; 2018 Jan; 144(1):7-34. PubMed ID: 29049853
[TBL] [Abstract][Full Text] [Related]
28. Akt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits.
Ghosh JC; Seo JH; Agarwal E; Wang Y; Kossenkov AV; Tang HY; Speicher DW; Altieri DC
Oncogene; 2019 Oct; 38(43):6926-6939. PubMed ID: 31406245
[TBL] [Abstract][Full Text] [Related]
29. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.
Pinho TS; Correia SC; Perry G; Ambrósio AF; Moreira PI
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2048-2059. PubMed ID: 30412792
[TBL] [Abstract][Full Text] [Related]
30. LonP1 regulates mitochondrial network remodeling through the PINK1/Parkin pathway during myoblast differentiation.
Huang S; Wang X; Yu J; Tian Y; Yang C; Chen Y; Chen H; Ge H
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1020-C1028. PubMed ID: 32936696
[TBL] [Abstract][Full Text] [Related]
31. The Sulfur-Linked Analogue of O-GlcNAc (S-GlcNAc) Is an Enzymatically Stable and Reasonable Structural Surrogate for O-GlcNAc at the Peptide and Protein Levels.
De Leon CA; Levine PM; Craven TW; Pratt MR
Biochemistry; 2017 Jul; 56(27):3507-3517. PubMed ID: 28627871
[TBL] [Abstract][Full Text] [Related]
32. Comparative Proteomics Reveals Dysregulated Mitochondrial O-GlcNAcylation in Diabetic Hearts.
Ma J; Banerjee P; Whelan SA; Liu T; Wei AC; Ramirez-Correa G; McComb ME; Costello CE; O'Rourke B; Murphy A; Hart GW
J Proteome Res; 2016 Jul; 15(7):2254-64. PubMed ID: 27213235
[TBL] [Abstract][Full Text] [Related]
33. Molecular Interrogation to Crack the Case of O-GlcNAc.
Estevez A; Zhu D; Blankenship C; Jiang J
Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184
[TBL] [Abstract][Full Text] [Related]
34. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
35. LONP1 downregulation with ageing contributes to osteoarthritis via mitochondrial dysfunction.
He Y; Ding Q; Chen W; Lin C; Ge L; Ying C; Xu K; Wu Z; Xu L; Ran J; Chen W; Wu L
Free Radic Biol Med; 2022 Oct; 191():176-190. PubMed ID: 36064070
[TBL] [Abstract][Full Text] [Related]
36. Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.
Hilgers RH; Xing D; Gong K; Chen YF; Chatham JC; Oparil S
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H513-22. PubMed ID: 22777418
[TBL] [Abstract][Full Text] [Related]
37. Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes.
Zhu-Mauldin X; Marsh SA; Zou L; Marchase RB; Chatham JC
J Biol Chem; 2012 Nov; 287(46):39094-106. PubMed ID: 22992728
[TBL] [Abstract][Full Text] [Related]
38. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
[TBL] [Abstract][Full Text] [Related]
39. Measuring O-GlcNAc cleavage by OGA and cell lysates on a peptide microarray.
Sharif S; Shi J; Bourakba M; Ruijtenbeek R; Pieters RJ
Anal Biochem; 2017 Sep; 532():12-18. PubMed ID: 28571750
[TBL] [Abstract][Full Text] [Related]
40. O-linked N-acetylglucosamine cycling regulates mitotic spindle organization.
Tan EP; Caro S; Potnis A; Lanza C; Slawson C
J Biol Chem; 2013 Sep; 288(38):27085-27099. PubMed ID: 23946484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
